Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effects of S-1 and Capecitabine in Combination With Oxaliplatin on the Coronary Artery Blood Flow in Patients Metastatic Gastrointestinal Tract Adenocarcinoma: a Randomized Phase II Study

NCT02216149 is registered in ClinicalTrials.gov with Heikki Joensuu as lead sponsor.

NCT NCT02216149
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02216149 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effects of S-1 and Capecitabine in Combination With Oxaliplatin on the Coronary Artery Blood Flow in Patients Metastatic Gastrointestinal Tract Adenocarcinoma: a Randomized Phase II Study
Lead sponsor
Heikki Joensuu
Phase
Phase 2
Overall status
Terminated
Start date
January 31, 2015
Completion date
August 31, 2018
Enrollment
20 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

colon cancer, esophagus cancer, rectum cancer, small bowel cancer, stomach cancer